HEAVYBIO (CEO YUJIA, LIN) participated in ‘BIO KOREA 5 (Bio Korea 10)’ held at COEX in Seoul for 12 days from Wednesday, May 3th to Friday, May 2023th.
HEAVYBIO is a global IVD raw material supplier located in Shenzhen, China. Its main products include antibodies, antigens, large-scale reagents for chemiluminescent immunosorbent assay (CLIA), and test papers. We comply with the Good Health Functional Food Manufacturing Practices (GMP) under ISO 13485 management and establish a major platform necessary for antibody antigen production.
HEAVYBIO, a research and development-based innovative technology company, deals with raw materials that are attracting attention in the field of in vitro analysis. It is a customized, personalized service that helps them save time and money in developing new products. In particular, it is emphasized that high-quality raw materials are provided at a reasonable price targeting the Korean market.
In November 2022, an in vitro screening kit approved by the Korean Ministry of Food and Drug Safety (MFDS) was manufactured using HEAVYBIO raw materials. The ambition is to supply highly competitive products and services to Korean in vitro testing kit manufacturers who are focusing on developing new products after the coronavirus pandemic.
HEAVYBIO, which has been increasing awareness since entering the Korean market in 2022, had more than 200 customers in Korea as of last year and generated $2 million in revenue. It is known that overseas sales in Japan, Europe, and Southeast Asia are also on the rise.
HEAVYBIO said, “We will do our best to stably settle in the Korean market and support Korean in vitro testing kit manufacturers so that they can take the lead in the global market.”
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. it went on
→ Go to the BIO KOREA 2023 news special page
